Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Cash from Operations (2020 - 2025)

Historic Cash from Operations for GoHealth (GOCO) over the last 6 years, with Q3 2025 value amounting to -$32.7 million.

  • GoHealth's Cash from Operations fell 16704.02% to -$32.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$68.3 million, marking a year-over-year decrease of 29455.4%. This contributed to the annual value of -$21.6 million for FY2024, which is 11979.73% down from last year.
  • Latest data reveals that GoHealth reported Cash from Operations of -$32.7 million as of Q3 2025, which was down 16704.02% from -$37.8 million recorded in Q2 2025.
  • GoHealth's 5-year Cash from Operations high stood at $95.5 million for Q3 2022, and its period low was -$226.6 million during Q4 2021.
  • In the last 5 years, GoHealth's Cash from Operations had a median value of -$12.2 million in 2024 and averaged -$12.3 million.
  • Its Cash from Operations has fluctuated over the past 5 years, first surged by 33781.03% in 2022, then crashed by 43602.8% in 2024.
  • Over the past 5 years, GoHealth's Cash from Operations (Quarter) stood at -$226.6 million in 2021, then skyrocketed by 81.91% to -$41.0 million in 2022, then soared by 273.91% to $71.3 million in 2023, then tumbled by 79.52% to $14.6 million in 2024, then plummeted by 323.58% to -$32.7 million in 2025.
  • Its last three reported values are -$32.7 million in Q3 2025, -$37.8 million for Q2 2025, and -$12.4 million during Q1 2025.